Sat Nov 08 20:18:00 UTC 2025: Here’s a news article summarizing the provided text:

Early Blood Tests Could Revolutionize Diabetes Detection in India

Mumbai, India – November 9, 2025 – A groundbreaking study by Indian researchers suggests a new approach to diabetes detection could significantly improve early diagnosis and treatment in a country grappling with a diabetes epidemic. Published in the Journal of Proteome Research, the study identifies specific molecules in the blood, called metabolites, that can serve as early warning signs for diabetes and associated kidney complications.

The research, conducted by IIT Bombay, Osmania Medical College, and Clarity Bio Systems, analyzed blood samples from healthy individuals, diabetics, and those with diabetic kidney disease. Researchers found distinct patterns in the levels of 26 metabolites that differed significantly between healthy individuals and those with diabetes, including lesser-known compounds such as valerobetaine, ribothymidine, and fructosyl-pyroglutamate. They found that they could identify the risk of diabetes earlier than with current tests.

The study, using dried blood spots collected via a simple finger-prick method, revealed that these metabolomic markers could potentially identify disease risk even before traditional tests can detect damage. This is particularly significant in India, where the Indian Council of Medical Research estimates that 11.4% of adults have diabetes and 15.3% are pre-diabetic. It is thought that 80% of people with NCDs remain undiagnosed or inadequately treated.

The identification of metabolic subgroups within the diabetic population also offers the potential for personalized care, allowing doctors to tailor interventions based on individual risk profiles.

While the findings are promising, researchers caution that the study had a limited sample size and requires further validation in larger, more diverse populations. The researchers are planning to explore how metabolomic markers perform across different age groups, ethnicities, and comorbidities. If validated, the study could pave the way for affordable, field-friendly tests that could transform diabetes management in India, shifting from reactive treatment to proactive prevention. However, translation into clinical practice faces challenges, including standardising lab protocols, ensuring regulatory approvals, and making the technology accessible.

“Type 2 diabetes is not just about high blood sugar; it disrupts multiple metabolic pathways that standard tests often miss,” explained Sneha Rana, the study’s first author from IIT Bombay. The findings offer hope for earlier intervention and improved health outcomes for millions of Indians at risk of or living with diabetes.

Read More